CIK 0000749647
- Non-accelerated filer
- Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521256615
- Phone
- +1 609-896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel and Corp Sec sold 920 shares at $1.88 ($1,730)
- 4 Grant or award Chief Medical Officer acquired 1,308 shares (grant or award)
- 4 Grant or award President and CEO acquired 2,534 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 21,896 shares (grant or award)
- 4 Open-market sale General Counsel and Corp Sec sold 11,800 shares at $1.75 ($20,674)
- 4 Grant or award Executive Chairman of Board acquired 42,519 shares (grant or award)
- 4 Grant or award President and CEO acquired 67,150 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 4,629 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,803 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 4,089 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,593 shares (grant or award)
- 4 Grant or award Executive Chairman of Board acquired 3,484 shares (grant or award)
- 4 Grant or award Director acquired 5,557 shares (grant or award)
- 4 Grant or award Director acquired 11,148 shares (grant or award)
- 4 Grant or award Director acquired 5,011 shares (grant or award)
- 4 Grant or award Director acquired 10,330 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,491 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 30 · 594 filings